In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
In the Lab
SKI cell biologists Junmei Yi and Xuejun Jiang
More Evidence that Cellular ‘Death by Iron’ Could Be Promising Avenue of Cancer Treatment

Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
In the Clinic
Anne Covey
No Scalpel Required: Targeting Liver Tumors with Interventional Radiology

Interventional radiology uses minimally invasive procedures that can treat some liver tumors as effectively as surgery.
Participants in Cycle for Survival
Treating Rare Cancers

Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.
Feature
A barred Plymouth Rock hen
How a Chicken Helped Solve the Mystery of Cancer

When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.
Feature
MSK medical oncologist Alexander Drilon
First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.
In the Lab
A chess match
Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy

New research on an experimental drug provides hope for better responses to immunotherapy.
Joseph Sun and Rebecca Delconte
Fasting Primes the Immune System’s Natural Killer Cells to Better Fight Cancer, New Study in Mice Finds

Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, while also improving their cancer-fighting ability.
Education
Group of diverse college students on roof of building.
MSK’s Summer Cancer Research Program Gives Opportunity to Diverse College Students

A summer program offers college students from underrepresented communities a chance to get valuable research experience.
In the Clinic
Cannabis oil is often heralded as an alternative cure for cancer
The Truth Behind Four Natural Cancer “Cures”

The internet is full of “miracle cures” for cancer and alleged surefire ways to prevent it, and well-meaning people may urge cancer patients to just tr...